Viewing Study NCT02664961


Ignite Creation Date: 2025-12-24 @ 11:51 AM
Ignite Modification Date: 2026-02-07 @ 4:24 AM
Study NCT ID: NCT02664961
Status: TERMINATED
Last Update Posted: 2019-07-23
First Post: 2016-01-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Sponsor:
Organization: